Publications by authors named "Edith Schneider"

Claim this Profile
I
ID3 promotes erythroid differentiation and is repressed by a TAL1-PRMT6 complex.
Vivien Heller, Lei Wang, Edith Schneider, Mirjam Gerstner, Luana Bajer

J Biol Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidating the importance and regulation of key enhancers for human MEIS1 expression.
Ping Xiang, Xining Yang, Leo Escano, Ishpreet Dhillon, Edith Schneider

Leukemia· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.
Torsten Diesinger, Alfred Lautwein, Sebastian Bergler, Dominik Buckert, Christian Renz, Edith Schneider

Can J Gastroenterol Hepatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
Torsten Diesinger, Vyacheslav Buko, Alfred Lautwein, Radovan Dvorsky, Elena Belonovskaya, Edith Schneider

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
Edith Schneider, Nicole Pochert, Christoph Ruess, Liam MacPhee, Leo Escano

Leukemia· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.
Edith Schneider, Anna Staffas, Linda Röhner, Erik D Malmberg, Arghavan Ashouri

Haematologica· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
is recurrently deleted in acute myeloid leukemia and required for efficient DNA double strand break repair.
Julia K Herzig, Lars Bullinger, Alpaslan Tasdogan, Philipp Zimmermann, Martin Schlegel, Edith Schneider

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1.
Ping Xiang, Wei Wei, Nicole Hofs, Jack Clemans-Gibbon, Tobias Maetzig, Edith Schneider

Blood Adv· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.
Edith Schneider, Anna Staffas, Linda Röhner, Kathrin Krowiorz, Michael Heuser

Exp Hematol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice.
Dan Ziegler, Edith Schneider, Frank G Boess, Lovisa Berggren, Frank Birklein

J Diabetes Complications· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of duloxetine compared with pregabalin and gabapentin in diabetic peripheral neuropathic pain: results from a German observational study.
Michael Happich, Edith Schneider, Frank G Boess, Stefan Wilhelm, Alexander Schacht

Clin J Pain· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient expectations in the treatment of painful diabetic polyneuropathy: results from a non-interventional study.
Edith Schneider, Dan Ziegler, Stefan Wilhelm, Alexander Schacht, Frank Birklein

Pain Med· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient preferences for outcomes of depression treatment in Germany: a choice-based conjoint analysis study.
Thomas M Zimmermann, Johannes Clouth, Michael Elosge, Matthias Heurich, Edith Schneider

J Affect Disord· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice?
Stefan Wilhelm, Frank G Boess, Ulrich Hegerl, Roland Mergl, Michael Linden, Edith Schneider

Expert Opin Drug Saf· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression treatment with duloxetine and reduction of inability to work.
Michael Happich, Edith Schneider, Stefan Wilhelm, Thomas Zimmermann, Alexander Schacht

Depress Res Treat· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine.
Edith Schneider, Michael Linden, Harald Weigmann, Thomas Wagner, Deborah Quail

BMC Psychiatry· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Peter M Wehmeier, Michael Kluge, Edith Schneider, Alexander Schacht, Thomas Wagner

Prog Neuropsychopharmacol Biol Psychiatry· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine: a new selective and dual-acting antidepressant.
Michael Bauer, Hans-Jürgen Möller, Edith Schneider

Expert Opin Pharmacother· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homer-1a/Vesl-1S enhances hippocampal synaptic transmission.
Sonia Hennou, Akihiko Kato, Edith M Schneider, Kenneth Lundstrom, Beat H Gähwiler

Eur J Neurosci· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel formulations of cetrorelix acetate in healthy men: pharmacodynamic effects and noncompartmental pharmacokinetics.
Katharina Erb, Klaus Junge, Birgit Pechstein, Edith Schneider, Hartmut Derendorf

J Clin Pharmacol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis